Benedetta Angeloni

Marcus Callister, MD

Dr. Marcus Callister is a clinical fellow in neurophysiology and movement disorders at the University of Toronto. He completed medical school at the University of Texas Southwestern Medical Center followed by neurology residency and a clinical neurophysiology - electromyography (EMG) fellowship at the Mayo Clinic in Arizona. His major interest is using movement clinical neurophysiology techniques to aid clinical diagnosis and guide treatment selection and response monitoring for medications, rehabilitation, non-invasive brain stimulation, and other treatment interventions. He and his wife Natalie are the happy parents of 5 energetic children.

Robert Chen, MA, MBBChir, MSc, FRCPC

Dr. Robert Chen received his MA and medical (MBBChir) degrees from University of Cambridge. He undertook Neurology residency at the University of Western Ontario (Canada), and fellowship at the National Institute of Neurological Disorders and Stroke in Bethesda, Maryland, USA. He is currently Professor of Medicine (Neurology) at University of Toronto, Senior Scientist at Krembil Research Institute, Editor-in-Chief of Clinical Neurophysiology and Associate Editor of Movement Disorders. His clinical and research interests include transcranial magnetic and ultrasound stimulation, neurophysiology and treatment of movement disorders, mapping of brain connectivity using functional magnetic imaging and electroencephalography, electromyography and neurophysiological assessment of the respiratory system. He has published over 410 research papers, a book on Transcranial Magnetic Stimulation and edited two volumes of Handbook of Clinical Neurology on Respiratory Neurobiology.

Naaz Desai

Talyta Grippe, MD, PhD

Talyta Grippe is a clinical fellow in neurophysiology and movement disorders at the University of Toronto. She completed her medical degree, neurology and clinical electrophysiology (EMG) residency in Brazil, followed by a PhD at Universidade Federal de Minas Gerais in collaboration with the University of Toronto. Talyta is passionate about using neurophysiological studies to improve the diagnosis and treatment of movement disorders. Her primary research interests focus on the use of neurophysiological techniques and non-invasive neuromodulation as tools for studying neurological physiology and exploring potential therapeutic applications. She is currently a member of the MDS Study Group on Clinical Neurophysiology in Movement Disorders.

Mark Hallett

Shabbir Merchant, MD

Shabbir Merchant, is Assistant Professor of Neurology at Harvard Medical School/ Beth Israel Deaconess Medical Center and Fellowship Director of Movement disorders program. His clinical practice involves treatment of neurological disorders with a special focus on the diagnosis and treatment of movement disorders. He has a special interest in clinical neurophysiology for objective diagnosis and phenotyping of movement disorders and directs the motor control physiology laboratory. He also utilizes ultrasound and EMG guided botulinum toxin injections for the precise identification of muscles for treatment and rehabilitation of a variety of neurological disorders such as dystonia’s and spasticity from various etiologies. He has leadership roles in the International Parkinson and Movement Disorder Society. He was the co-chair of the Task Force on Clinical Neurophysiology in Movement disorders and currently serves as the chair of the executive committee of Study Group on Clinical Neurophysiology in Movement Disorders.

Nicolas Phielipp, MD

Dr Nicolas Phielipp, a native from Patagonia Argentina, is a graduate of the University of Buenos Aires Argentina, where he completed his neurology residency and a clinical movement disorders fellowship. He completed further training with a clinical fellowship in movement disorders and neurophysiology at the University of Toronto. He is currently an Associate Professor at the University of California Irvine, where he directs the clinical fellowship in Movement Disorders and the clinical neurophysiology and deep phenotyping laboratory.